Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis
Completed · Phase 2 · Has a placebo group
Conditions studied: Symptomatic Knee Osteoarthritis
In brief
This was a double-blinded, two-arm, phase 2a study to assess efficacy, safety and tolerability of DFV890 in participants with symptomatic knee osteoarthritis.
Key facts
- Study ID
- NCT04886258
- Run by
- Novartis Pharmaceuticals
- People needed
- 115
- Starts
- 2021-09-20
- Expected to finish
- 2024-12-23
- Last updated by the study team
- 2026-03-31
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ARENSIA Explor Med Res Clinic — Phoenix, Arizona, United States
- TriWest Reserach Associates — El Cajon, California, United States
- Skylight Health Res Inc Color Spr — Colorado Springs, Colorado, United States
- IRIS Research and Development — Plantation, Florida, United States
- Conquest Research — Winter Park, Florida, United States
- Ctr for Adv Research and Education — Gainesville, Georgia, United States
- Northwestern University — Chicago, Illinois, United States
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — San Miguel, Tucumán Province, Argentina
- Novartis Investigative Site — San Miguel de Tucumán, Argentina
- Novartis Investigative Site — Brno, Czech Republic, Czechia
- Novartis Investigative Site — Nový Jičín, Czechia
- Novartis Investigative Site — Prague, Czechia
- Novartis Investigative Site — Uherské Hradiště, Czechia
- Novartis Investigative Site — Bad Doberan, Germany
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Leipzig, Germany
- Novartis Investigative Site — Kecskemét, Bács-Kiskun county, Hungary
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Miskolc, Hungary
- Novartis Investigative Site — Veszprém, Hungary
- Novartis Investigative Site — Cluj-Napoca, Cluj, Romania
- Novartis Investigative Site — Bucharest, Romania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.